Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data.

Impact of perioperative COVID-19 infection on postoperative complication in cesarean section using Korean National Health insurance data.

Publication date: Jul 11, 2024

The vulnerability during pregnancy has raised concerns about the potential impact of COVID-19 on obstetric anesthesia, an essential aspect of maternal care during cesarean section procedures. To evaluate the influence of COVID-19 infection on obstetric anesthesia during cesarean section, we analyzed the data from Korean National Health Insurance System (NHIS). This retrospective study utilized data from Korean NHIS. We included patients admitted with operation codes specific to cesarean section between January 1, 2020, and December 31, 2021. We classified patients into a COVID (+) group with a diagnosis code (U071) 30 days around surgery and a COVID (-) group without the code in the same period. The primary outcome was 30-day mortality that was defined as death within 30 days of admission due to any causes. Secondary outcomes were pulmonary complications (pneumonia, acute respiratory distress syndrome [ARDS], pulmonary thromboembolism [PTE], or unexpected postoperative mechanical ventilation), ICU admission, cardiac arrest, myocardial infarction [MI], other thromboembolic events, surgical site infection, sepsis, acute renal failure [ARF], and hepatic failure. Among 75,268 patients who underwent cesarean section, 107 had a COVID-19 diagnosis code, while 75,161 did not. After 1:4 propensity score matching (PSM), 535 patients were included in each group. 30-day mortality showed no significant differences between the two groups both before and after PSM. The COVID (+) group demonstrated significantly elevated rates of pneumonia, ARDS, PTE, and surgical site infection both before and after PSM. Hospital length of stay and admission costs were also significantly longer and higher, respectively, in the COVID (+) group before and after PSM. In subgroup analysis, no differences were observed in mortality and postoperative complications based on the anesthesia method after matching. COVID-19 infection is associated with increased rates of postoperative complications, including pneumonia, ARDS, PTE, surgical site infection, longer hospital stays, and increased admission costs, in patients who underwent cesarean section.

Open Access PDF

Concepts Keywords
30days Adult
Korean Anesthesia
Pneumonia Cesarean Section
Pregnancy Cesarean section
Renal COVID-19
COVID-19
Epidemiology
Female
Humans
Length of Stay
National Health Programs
Perioperative Period
Postoperative Complications
Pregnancy
Republic of Korea
Retrospective Studies
SARS-CoV-2

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH postoperative complication
disease MESH death
disease MESH causes
disease MESH complications
disease MESH pneumonia
disease MESH acute respiratory distress syndrome
disease MESH pulmonary thromboembolism
disease MESH cardiac arrest
disease MESH myocardial infarction
disease MESH surgical site infection
disease MESH sepsis
disease MESH acute renal failure
disease MESH hepatic failure
drug DRUGBANK Coenzyme M
disease VO Severe acute respiratory syndrome coronavirus 2
disease VO population
disease VO protocol
disease IDO history
disease VO vaccination
drug DRUGBANK Acetylsalicylic acid
disease MESH emergency
disease MESH venous thromboembolism
disease MESH Comorbidity
disease MESH congestive heart failure
disease MESH cardiac arrhythmias
disease MESH hypertension
disease MESH neurologic disorders
disease MESH pulmonary disease
disease MESH diabetes mellitus
disease MESH hypothyroidism
disease MESH renal failure
disease MESH liver disease
disease MESH peptic ulcer
disease MESH acquired immune deficiency syndrome
disease IDO immunodeficiency
disease MESH virus infection
disease MESH lymphoma
disease MESH cancer
disease MESH metastasis
disease MESH rheumatoid arthritis
pathway KEGG Rheumatoid arthritis
disease MESH obesity
disease MESH weight loss
disease IDO blood
disease MESH anemia
disease MESH alcohol abuse
disease MESH drug abuse
disease MESH psychoses
disease MESH kidney disease
disease VO USA
disease MESH gestational diabetes mellitus
drug DRUGBANK Oxygen
disease MESH total lung capacity
disease VO pregnant women
disease MESH hypoxemic respiratory failure
disease IDO cell
disease IDO susceptibility
disease MESH cerebrovascular accidents
disease VO effective
disease VO cerebrospinal fluid
disease VO Viruses
disease MESH fetal distress
disease MESH maternal deaths
disease VO effectiveness
disease IDO process
disease MESH morbidity
disease MESH Post COVID Conditions
disease MESH clinical course
drug DRUGBANK Trestolone

Original Article

(Visited 3 times, 1 visits today)